NUS - Nu Skin Enterprises, Inc.
| Previous Close | 29.79 |
| Open | 29.55 |
| Bid | 29.71 x 900 |
| Ask | 29.72 x 800 |
| Day's Range | 29.37 - 30.23 |
| 52 Week Range | 29.10 - 64.90 |
| Volume | 671,348 |
| Avg. Volume | 528,862 |
| Market Cap | 1.658B |
| Beta (5Y Monthly) | 0.58 |
| PE Ratio (TTM) | 9.63 |
| EPS (TTM) | 3.10 |
| Earnings Date | Apr 27, 2020 - May 03, 2020 |
| Forward Dividend & Yield | 1.48 (4.86%) |
| Ex-Dividend Date | Nov 26, 2019 |
| 1y Target Est | 33.71 |
- Thomson Reuters StreetEvents
Edited Transcript of NUS earnings conference call or presentation 12-Feb-20 10:00pm GMT
Q4 2019 NU Skin Enterprises Inc Earnings Call
- Simply Wall St.
Nu Skin Enterprises, Inc. Analysts Are Cutting Their Estimates: Here's What You Need To Know
There's been a notable change in appetite for Nu Skin Enterprises, Inc. (NYSE:NUS) shares in the week since its yearly...
- Zacks
Nu Skin's (NUS) Q4 Earnings Meet Estimates, Down Year on Year
Nu Skin's (NUS) fourth-quarter 2019 results reflect lower earnings and sales. Further, management expects the coronavirus outbreak to hurt Mainland China sales in 2020.
- Zacks
Nu Skin Enterprises (NUS) Q4 Earnings Match Estimates
Nu Skin (NUS) delivered earnings and revenue surprises of 0.00% and 0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- MarketWatch
Nu Skin stock drops more than 10% on China profit warning
Nu Skin Enterprises Inc. shares dropped in the extended session Wednesday after the maker of supplements and personal care products blamed its disappointing outlook on sales in China due to the COVAD-19 coronavirus. Nu Skin shares fell 12% after hours, following a 3.4% rise in the regular session to close at $35.79. Nu Skin expects earnings of 23 cents to 33 cents a share on revenue of $480 million to $510 million for the first quarter, while analysts surveyed by FactSet had forecast earnings of 74 cents a share on revenue of $596.6 million. For the year, Nu Skin forecast earnings of $2 to $2.40 a share on revenue of $2.17 billion to $2.3 billion, while analysts were looking for $3.27 a share on revenue of $2.44 billion. "Following the recent coronavirus outbreak, we placed a temporary hold on all in-person meetings with our sales force and customers in Mainland China," said Ritch Wood, Nu Skin chief executive, in a statement. "While we expect the outbreak to significantly impact our business in the near term, we remain confident in our long-term opportunity in Mainland China and around the world. While the duration and global impact remain uncertain, our guidance reflects our current understanding of the situation." The company reported fourth-quarter net income of $40.1 million, or 72 cents a share, compared with a loss of $17.8 million, or 32 cents a share, in the year-ago period. Revenue declined to $583.4 million from $683.3 million in the year-ago quarter. Analysts had forecast earnings of 72 cents on revenue of $582.1 million.
- PR Newswire
Nu Skin Enterprises Reports Fourth-Quarter And 2019 Results And Provides 2020 Guidance
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced fourth-quarter and 2019 financial results.
- PR Newswire
Nu Skin Enterprises Announces Dividend Increase
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has increased the quarterly cash dividend to $0.375 from the previous $0.370 per share. The quarterly dividend will be paid on March 11, 2020, to shareholders of record on Feb. 28, 2020.
- Zacks
Here's How Nu Skin (NUS) is Placed Ahead of Q4 Earnings
Impacts from foreign currency headwinds are likely to get reflected in Nu Skin's (NUS) fourth-quarter 2019 results. However, the company is on track with product launches and programs to bolster sales leaders.
- Zacks
Earnings Preview: Nu Skin Enterprises (NUS) Q4 Earnings Expected to Decline
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Should We Worry About Nu Skin Enterprises, Inc.'s (NYSE:NUS) P/E Ratio?
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). To keep it...
- PR Newswire
Nu Skin Enterprises To Announce Fourth-Quarter And 2019 Results
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release fourth-quarter and full-year 2019 results after the market closes on Wednesday, Feb. 12. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss historical results and upcoming business initiatives.
- PR Newswire
Grōv Technologies Launches with Unrivaled, Commercial-Scale, Indoor Growing System for Animal Feed
Grōv Technologies today announced its indoor, fully-automated animal feed production system with the capability to revolutionize the $350 billion global animal feed marketplace. The system, called the Grōv Pod, integrates sustainable technologies and science-based growing protocols into a controlled environment agriculture (CEA) system that uses less than 2 percent of the water and a fraction of the land needed for traditional farming. Grōv will unveil its new technology at the International Consumer Electronics Show (CES) in Las Vegas on Jan. 7 to 10, 2020.
- Simply Wall St.
Based On Its ROE, Is Nu Skin Enterprises, Inc. (NYSE:NUS) A High Quality Stock?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
- Thomson Reuters StreetEvents
Edited Transcript of NUS earnings conference call or presentation 5-Nov-19 10:00pm GMT
Q3 2019 NU Skin Enterprises Inc Earnings Call
- Insider Monkey
Do Hedge Funds Love Nu Skin Enterprises, Inc. (NUS)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]
- Zacks
Why Is Nu Skin (NUS) Down 4.4% Since Last Earnings Report?
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Nu Skin Plunges in 6 Months, Mainland China Woes Persist
Nu Skin (NUS) is battling headwinds in Mainland China thanks to increased scrutiny by the government. Also, management provides an unimpressive view for 2019.
- Simply Wall St.
Nu Skin Enterprises (NYSE:NUS) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
- Zacks
Nu Skin's (NUS) Q3 Earnings Beat Estimates, Revenues Miss
Nu Skin's (NUS) third-quarter earnings are affected by limited sales meetings in Mainland China.
- Zacks
Nu Skin Enterprises (NUS) Tops Q3 Earnings Estimates
Nu Skin (NUS) delivered earnings and revenue surprises of 3.95% and -2.57%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
Nu Skin Enterprises Reports Third-Quarter 2019 Results
PROVO, Utah , Nov. 5, 2019 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced third-quarter 2019 results. Executive Summary Q3 2019 vs. Prior-Year Quarter Revenue: $589.9 million; (13%) ...
- PR Newswire
Nu Skin Enterprises Announces Quarterly Dividend
PROVO, Utah , Nov. 5, 2019 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has declared a quarterly cash dividend of $0.37 per share, which will be paid on ...
- Zacks
Here's How Nu Skin (NUS) Looks Just Ahead of Q3 Earnings
Nu Skin's (NUS) third-quarter 2019 results are expected to reflect impacts of foreign currency headwinds.
- Zacks
Earnings Preview: Nu Skin Enterprises (NUS) Q3 Earnings Expected to Decline
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
